Position in INMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,253,679
+$766,456 QoQ
Shares Held
85,751
+158.5% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 188 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 0%
Shared 52%
None 48%
Common Shares in INMD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $7,924,963,064 across 31 Medical Devices names. INMD ranks #30 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
8,167,185 | $2,571,356,522 | |
| 2 | EW |
Edwards Lifesciences Corp
|
16,827,967 | $1,522,257,889 | |
| 3 | ABT |
Abbott Laboratories
|
8,304,709 | $753,569,291 | |
| 4 | STE |
STERIS plc
|
3,502,897 | $737,605,017 | |
| 5 | BSX |
Boston Scientific Corp
|
15,301,828 | $653,082,016 | |
| 6 | DXCM |
Dexcom Inc
|
8,527,471 | $574,325,169 | |
| 7 | MDT |
Medtronic plc
|
6,474,476 | $506,498,254 | |
| 8 | LIVN |
LivaNova PLC
|
1,739,167 | $143,011,699 |
All Filings in INMD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,253,679 | 85,751 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $487,223 | 33,167 | Shares | Defined | 2026-02-17 | |
| 2023-03-31 | $867,010 | 27,128 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $994,065 | 27,845 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $871,959 | 29,954 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,700,245 | 75,870 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,400,736 | 65,043 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,919,659 | 55,535 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,092,620 | 13,124 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||